{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:00:22Z","timestamp":1792670422354,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100018818","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["OTKA K143576"],"award-info":[{"award-number":["OTKA K143576"]}],"id":[{"id":"10.13039\/501100018818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018818","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["TKP2021-EGA-28"],"award-info":[{"award-number":["TKP2021-EGA-28"]}],"id":[{"id":"10.13039\/501100018818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019185","name":"HORIZON EUROPE Global Challenges and European Industrial Competitiveness","doi-asserted-by":"publisher","award":["No. 739"],"award-info":[{"award-number":["No. 739"]}],"id":[{"id":"10.13039\/100019185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019185","name":"HORIZON EUROPE Global Challenges and European Industrial Competitiveness","doi-asserted-by":"publisher","award":["593"],"award-info":[{"award-number":["593"]}],"id":[{"id":"10.13039\/100019185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40257-025-00954-8","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:50:25Z","timestamp":1749124225000},"page":"667-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is There a Place for Biologics in Acne?"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2119-9501","authenticated-orcid":false,"given":"Lajos","family":"Kem\u00e9ny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f6n\u00edz","family":"Degovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korn\u00e9lia","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"954_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s13555-018-0224-7","volume":"8","author":"G Fabbrocini","year":"2018","unstructured":"Fabbrocini G, Cacciapuoti S, Monfrecola G. A qualitative investigation of the impact of acne on health-related quality of life (HRQL): development of a conceptual model. Dermatol Ther (Heidelb). 2018;8:85\u201399. https:\/\/doi.org\/10.1007\/s13555-018-0224-7.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"954_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/jid.2010.264","volume":"131","author":"JA Halvorsen","year":"2011","unstructured":"Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Investig Dermatol. 2011;131:363\u201370. https:\/\/doi.org\/10.1038\/jid.2010.264.","journal-title":"J Investig Dermatol"},{"key":"954_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40168-018-0558-5","volume":"6","author":"AM O\u2019Neill","year":"2018","unstructured":"O\u2019Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome. 2018;6:177. https:\/\/doi.org\/10.1186\/s40168-018-0558-5.","journal-title":"Microbiome"},{"key":"954_CR4","doi-asserted-by":"publisher","first-page":"15962","DOI":"10.3390\/ijms242115962","volume":"24","author":"K Szab\u00f3","year":"2023","unstructured":"Szab\u00f3 K, Bolla BS, Erdei L, Balogh F, Kem\u00e9ny L. Are the cutaneous microbiota a guardian of the skin\u2019s physical barrier? The intricate relationship between skin microbes and barrier integrity. Int J Mol Sci. 2023;24:15962. https:\/\/doi.org\/10.3390\/ijms242115962.","journal-title":"Int J Mol Sci"},{"key":"954_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/jdv.19540","volume":"38","author":"B Dreno","year":"2024","unstructured":"Dreno B, Dekio I, Baldwin H, Demessant AL, Dagnelie M, Khammari A, et al. Acne microbiome: from phyla to phylotypes. J Eur Acad Dermatol Venereol. 2024;38:657\u201364. https:\/\/doi.org\/10.1111\/jdv.19540.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"954_CR6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1046\/j.1365-2133.2000.03531.x","volume":"142","author":"WJ Cunliffe","year":"2000","unstructured":"Cunliffe WJ, Holland DB, Clark SM, Stables GI. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol. 2000;142:1084\u201391. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03531.x.","journal-title":"Br J Dermatol"},{"key":"954_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.0906-6705.2005.0285a.x","volume":"14","author":"CC Zouboulis","year":"2005","unstructured":"Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, et al. What is the pathogenesis of acne? Exp Dermatol. 2005;14:143\u2013143. https:\/\/doi.org\/10.1111\/j.0906-6705.2005.0285a.x.","journal-title":"Exp Dermatol"},{"key":"954_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/858176","volume":"2010","author":"M Ottaviani","year":"2010","unstructured":"Ottaviani M, Camera E, Picardo M. Lipid mediators in acne. Mediat Inflamm. 2010;2010:1\u20136. https:\/\/doi.org\/10.1155\/2010\/858176.","journal-title":"Mediat Inflamm"},{"key":"954_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2100749118","author":"C Zhang","year":"2021","unstructured":"Zhang C, Chinnappan M, Prestwood CA, Edwards M, Artami M, Thompson BM, et al. Interleukins 4 and 13 drive lipid abnormalities in skin cells through regulation of sex steroid hormone synthesis. Proc Natl Acad Sci. 2021. https:\/\/doi.org\/10.1073\/pnas.2100749118.","journal-title":"Proc Natl Acad Sci"},{"key":"954_CR10","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","volume":"169","author":"J Kim","year":"2002","unstructured":"Kim J, Ochoa M-T, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169:1535\u201341. https:\/\/doi.org\/10.4049\/jimmunol.169.3.1535.","journal-title":"J Immunol"},{"key":"954_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/intimm\/dxg068","volume":"15","author":"A Pivarcsi","year":"2003","unstructured":"Pivarcsi A. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol. 2003;15:721\u201330. https:\/\/doi.org\/10.1093\/intimm\/dxg068.","journal-title":"Int Immunol"},{"key":"954_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/jid.2013.309","volume":"134","author":"M Qin","year":"2014","unstructured":"Qin M, Pirouz A, Kim M-H, Krutzik SR, Garb\u00e1n HJ, Kim J. Propionibacterium acnes induces IL-1\u03b2 secretion via the NLRP3 inflammasome in human monocytes. J Investig Dermatol. 2014;134:381\u20138. https:\/\/doi.org\/10.1038\/jid.2013.309.","journal-title":"J Investig Dermatol"},{"key":"954_CR13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.0022-202X.2005.23705.x","volume":"124","author":"I Nagy","year":"2005","unstructured":"Nagy I, Pivarcsi A, Koreck A, Sz\u00e9ll M, Urb\u00e1n E, Kem\u00e9ny L. Distinct strains of propionibacterium acnes induce selective human \u03b2-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Investig Dermatol. 2005;124:931\u20138. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23705.x.","journal-title":"J Investig Dermatol"},{"key":"954_CR14","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1468-3083.2010.03896.x","volume":"25","author":"D Ben-Amitai","year":"2011","unstructured":"Ben-Amitai D, Laron Z. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. J Eur Acad Dermatol Venereol. 2011;25:950\u20134. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03896.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"954_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/MOL.0b013e328352dd03","volume":"23","author":"I Bakan","year":"2012","unstructured":"Bakan I, Laplante M. Connecting mTORC1 signaling to SREBP-1 activation. Curr Opin Lipidol. 2012;23:226\u201334. https:\/\/doi.org\/10.1097\/MOL.0b013e328352dd03.","journal-title":"Curr Opin Lipidol"},{"key":"954_CR16","doi-asserted-by":"publisher","first-page":"e1000527","DOI":"10.1371\/journal.ppat.1000527","volume":"5","author":"PA Grange","year":"2009","unstructured":"Grange PA, Ch\u00e9reau C, Raingeaud J, Nicco C, Weill B, Dupin N, et al. Production of superoxide anions by keratinocytes initiates P. acnes-induced inflammation of the skin. PLoS Pathog. 2009;5:e1000527. https:\/\/doi.org\/10.1371\/journal.ppat.1000527.","journal-title":"PLoS Pathog"},{"key":"954_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1365-2133.2004.05762.x","volume":"150","author":"GM Graham","year":"2004","unstructured":"Graham GM, Farrar MD, Cruse-Sawyer JE, Holland KT, Ingham E. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Bri J Dermatol. 2004;150:421\u20138. https:\/\/doi.org\/10.1046\/j.1365-2133.2004.05762.x.","journal-title":"Bri J Dermatol"},{"key":"954_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.0022-202X.2005.23848.x","volume":"125","author":"E Papakonstantinou","year":"2005","unstructured":"Papakonstantinou E, Aletras AJ, Glass E, Tsogas P, Dionyssopoulos A, Adjaye J, et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Investig Dermatol. 2005;125:673\u201384. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23848.x.","journal-title":"J Investig Dermatol"},{"key":"954_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00403-017-1769-5","volume":"309","author":"R Di Caprio","year":"2017","unstructured":"Di Caprio R, Balato A, Caiazzo G, Lembo S, Raimondo A, Fabbrocini G, et al. IL-36 cytokines are increased in acne and hidradenitis suppurativa. Arch Dermatol Res. 2017;309:673\u20138. https:\/\/doi.org\/10.1007\/s00403-017-1769-5.","journal-title":"Arch Dermatol Res"},{"key":"954_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/jid.2013.334","volume":"134","author":"GW Agak","year":"2014","unstructured":"Agak GW, Qin M, Nobe J, Kim M-H, Krutzik SR, Tristan GR, et al. Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J Investig Dermatol. 2014;134:366\u201373. https:\/\/doi.org\/10.1038\/jid.2013.334.","journal-title":"J Investig Dermatol"},{"key":"954_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/jid.2014.290","volume":"135","author":"M Kistowska","year":"2015","unstructured":"Kistowska M, Meier B, Proust T, Feldmeyer L, Cozzio A, Kuendig T, et al. Propionibacterium acnes promotes Th17 and Th17\/Th1 responses in acne patients. J Investig Dermatol. 2015;135:110\u20138. https:\/\/doi.org\/10.1038\/jid.2014.290.","journal-title":"J Investig Dermatol"},{"key":"954_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105238","volume":"9","author":"H-L Kelh\u00e4l\u00e4","year":"2014","unstructured":"Kelh\u00e4l\u00e4 H-L, Palatsi R, Fyhrquist N, Lehtim\u00e4ki S, V\u00e4yrynen JP, Kallioinen M, et al. IL-17\/Th17 pathway is activated in acne lesions. PLoS ONE. 2014;9: e105238. https:\/\/doi.org\/10.1371\/journal.pone.0105238.","journal-title":"PLoS ONE"},{"key":"954_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0625.1998.tb00323.x","volume":"7","author":"AM Layton","year":"1998","unstructured":"Layton AM, Morris C, Cunliffe WJ, Ingham E. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol. 1998;7:191\u20137. https:\/\/doi.org\/10.1111\/j.1600-0625.1998.tb00323.x.","journal-title":"Exp Dermatol"},{"key":"954_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248650","volume":"16","author":"L Yang","year":"2021","unstructured":"Yang L, Shou Y-H, Yang Y-S, Xu J-H. Elucidating the immune infiltration in acne and its comparison with rosacea by integrated bioinformatics analysis. PLoS ONE. 2021;16: e0248650. https:\/\/doi.org\/10.1371\/journal.pone.0248650.","journal-title":"PLoS ONE"},{"key":"954_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/microorganisms9020303","volume":"9","author":"C Mayslich","year":"2021","unstructured":"Mayslich C, Grange PA, Dupin N. Cutibacterium acnes as an opportunistic pathogen: an update of its virulence-associated factors. Microorganisms. 2021;9:303. https:\/\/doi.org\/10.3390\/microorganisms9020303.","journal-title":"Microorganisms"},{"key":"954_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1469-0691.2009.02747.x","volume":"15","author":"A Holmberg","year":"2009","unstructured":"Holmberg A, Lood R, M\u00f6rgelin M, S\u00f6derquist B, Holst E, Collin M, et al. Biofilm formation by Propionibacterium acnes is a characteristic of invasive isolates. Clin Microbiol Infect. 2009;15:787\u201395. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02747.x.","journal-title":"Clin Microbiol Infect"},{"key":"954_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.ijmm.2018.09.005","volume":"308","author":"T Kuehnast","year":"2018","unstructured":"Kuehnast T, Cakar F, Weinh\u00e4upl T, Pilz A, Selak S, Schmidt MA, et al. Comparative analyses of biofilm formation among different Cutibacterium acnes isolates. Int J Med Microbiol. 2018;308:1027\u201335. https:\/\/doi.org\/10.1016\/j.ijmm.2018.09.005.","journal-title":"Int J Med Microbiol"},{"key":"954_CR28","doi-asserted-by":"publisher","first-page":"21104","DOI":"10.1038\/s41598-022-25436-3","volume":"12","author":"I Cavallo","year":"2022","unstructured":"Cavallo I, Sivori F, Truglio M, De Maio F, Lucantoni F, Cardinali G, et al. Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents. Sci Rep. 2022;12:21104. https:\/\/doi.org\/10.1038\/s41598-022-25436-3.","journal-title":"Sci Rep"},{"key":"954_CR29","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jid.2018.01.007","volume":"138","author":"E-J Choi","year":"2018","unstructured":"Choi E-J, Lee HG, Bae I-H, Kim W, Park J, Lee TR, et al. Propionibacterium acnes-derived extracellular vesicles promote acne-like phenotypes in human epidermis. J Investig Dermatol. 2018;138:1371\u20139. https:\/\/doi.org\/10.1016\/j.jid.2018.01.007.","journal-title":"J Investig Dermatol"},{"key":"954_CR30","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.jid.2016.06.615","volume":"136","author":"Y Yu","year":"2016","unstructured":"Yu Y, Champer J, Agak GW, Kao S, Modlin RL, Kim J. Different propionibacterium acnes phylotypes induce distinct immune responses and express unique surface and secreted proteomes. J Investig Dermatol. 2016;136:2221\u20138. https:\/\/doi.org\/10.1016\/j.jid.2016.06.615.","journal-title":"J Investig Dermatol"},{"key":"954_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12864-016-2489-5","volume":"17","author":"GJM Christensen","year":"2016","unstructured":"Christensen GJM, Scholz CFP, Enghild J, Rohde H, Kilian M, Th\u00fcrmer A, et al. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. BMC Genom. 2016;17:152. https:\/\/doi.org\/10.1186\/s12864-016-2489-5.","journal-title":"BMC Genom"},{"key":"954_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/exd.14467","volume":"31","author":"M-A Dagnelie","year":"2022","unstructured":"Dagnelie M-A, Corvec S, Timon-David E, Khammari A, Dr\u00e9no B. Cutibacterium acnes and Staphylococcus epidermidis: the unmissable modulators of skin inflammatory response. Exp Dermatol. 2022;31:406\u201312. https:\/\/doi.org\/10.1111\/exd.14467.","journal-title":"Exp Dermatol"},{"key":"954_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/jid.2010.328","volume":"131","author":"I Wanke","year":"2011","unstructured":"Wanke I, Steffen H, Christ C, Krismer B, G\u00f6tz F, Peschel A, et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Investig Dermatol. 2011;131:382\u201390. https:\/\/doi.org\/10.1038\/jid.2010.328.","journal-title":"J Investig Dermatol"},{"key":"954_CR34","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nm.2062","volume":"15","author":"Y Lai","year":"2009","unstructured":"Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med. 2009;15:1377\u201382. https:\/\/doi.org\/10.1038\/nm.2062.","journal-title":"Nat Med"},{"key":"954_CR35","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/sj.jid.5701070","volume":"128","author":"U Ohnemus","year":"2008","unstructured":"Ohnemus U, Kohrmeyer K, Houdek P, Rohde H, Wladykowski E, Vidal S, et al. Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J Investig Dermatol. 2008;128:906\u201316. https:\/\/doi.org\/10.1038\/sj.jid.5701070.","journal-title":"J Investig Dermatol"},{"key":"954_CR36","doi-asserted-by":"publisher","first-page":"12815","DOI":"10.1038\/s41598-020-69677-6","volume":"10","author":"BS Bolla","year":"2020","unstructured":"Bolla BS, Erdei L, Urb\u00e1n E, Buri\u00e1n K, Kem\u00e9ny L, Szab\u00f3 K. Cutibacterium acnes regulates the epidermal barrier properties of HPV-KER human immortalized keratinocyte cultures. Sci Rep. 2020;10:12815. https:\/\/doi.org\/10.1038\/s41598-020-69677-6.","journal-title":"Sci Rep"},{"key":"954_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/bjd.14967","volume":"176","author":"K Szab\u00f3","year":"2017","unstructured":"Szab\u00f3 K, Erdei L, Bolla BSz, Tax G, B\u00edr\u00f3 T, Kem\u00e9ny L. Factors shaping the composition of the cutaneous microbiota. Br J Dermatol. 2017;176:344\u201351. https:\/\/doi.org\/10.1111\/bjd.14967.","journal-title":"Br J Dermatol"},{"key":"954_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jmb.2012.09.021","volume":"425","author":"M Blech","year":"2013","unstructured":"Blech M, Peter D, Fischer P, Bauer MMT, Hafner M, Zeeb M, et al. One target\u2014two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1\u03b2. J Mol Biol. 2013;425:94\u2013111. https:\/\/doi.org\/10.1016\/j.jmb.2012.09.021.","journal-title":"J Mol Biol"},{"key":"954_CR39","unstructured":"Efficacy and safety study of gevokizumab to treat moderate to severe acne vulgaris. (XOMA (US) LLC). ClinicalTrialsGov ID NCT01498874. 2014. https:\/\/Clinicaltrials.gov\/study\/NCT01498874."},{"key":"954_CR40","unstructured":"XOMA announces encouraging interim results from gevokizumab phase 2 study for moderate to severe acne vulgaris. (XOMA (US) LLC). 2013."},{"key":"954_CR41","doi-asserted-by":"crossref","unstructured":"XOMA reports fourth quarter and full-year 2015 financial results 2016. (XOMA (US) LLC). https:\/\/investors.xoma.com\/news-events\/press-releases\/detail\/288\/xoma-reports-fourth-quarter-and-full-year-2015-financial.","DOI":"10.1016\/S1351-4210(15)30076-7"},{"key":"954_CR42","unstructured":"A study to evaluate the efficacy and safety of imsidolimab (ANB019) in the treatment of participants with acne vulgaris. (AnaptysBio Inc.) ClinicalTrialsGov ID. 2023. NCT04856917."},{"key":"954_CR43","unstructured":"A randomized, subject and investigator blinded, placebocontrolled, multi-center study in parallel groups to assess the efficacy and safety of CJM112 in patients with moderate to severe inflammatory acne. (Novartis. ) ClinicalTrialsGov, NCT02998671. 2017. https:\/\/cdn.clinicaltrials.gov\/Large-Docs\/71\/NCT02998671\/SAP_001.pdf."},{"key":"954_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2022.2138691","volume":"34","author":"DM Thiboutot","year":"2023","unstructured":"Thiboutot DM, Craft N, Rissmann R, Gatlik E, Souqui\u00e8res M, Jones J, et al. Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne. J Dermatol Treat. 2023;34:1. https:\/\/doi.org\/10.1080\/09546634.2022.2138691.","journal-title":"J Dermatol Treat"},{"key":"954_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2340\/00015555-0046","volume":"86","author":"E Campione","year":"2006","unstructured":"Campione E, Mazzotta A, Bianchi L, Chimenti S. Severe acne successfully treated with etanercept. Acta Derm Venereol. 2006;86:256\u20137. https:\/\/doi.org\/10.2340\/00015555-0046.","journal-title":"Acta Derm Venereol"},{"key":"954_CR46","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1365-2230.2010.03998.x","volume":"36","author":"MLA Schuttelaar","year":"2011","unstructured":"Schuttelaar MLA, Leeman FWJ. Sustained remission of nodular inflammatory acne after treatment with infliximab. Clin Exp Dermatol. 2011;36:670\u20131. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03998.x.","journal-title":"Clin Exp Dermatol"},{"key":"954_CR47","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jaad.2005.06.008","volume":"55","author":"M Shirakawa","year":"2006","unstructured":"Shirakawa M, Uramoto K, Harada FA. Treatment of acne conglobata with infliximab. J Am Acad Dermatol. 2006;55:344\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2005.06.008.","journal-title":"J Am Acad Dermatol"},{"key":"954_CR48","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/jamadermatol.2013.6678","volume":"149","author":"FL Sand","year":"2013","unstructured":"Sand FL, Thomsen SF. Adalimumab for the treatment of refractory acne conglobata. JAMA Dermatol. 2013;149:1306. https:\/\/doi.org\/10.1001\/jamadermatol.2013.6678.","journal-title":"JAMA Dermatol"},{"key":"954_CR49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000537914","volume":"10","author":"N Schettini","year":"2024","unstructured":"Schettini N, Marzola E, Pacetti L, Cavaliere S, Bettoli V. A case of dissecting cellulitis of the scalp, hidradenitis suppurativa, and conglobate acne successfully treated with secukinumab. Skin Appendage Disord. 2024;10:232\u20135. https:\/\/doi.org\/10.1159\/000537914.","journal-title":"Skin Appendage Disord"},{"key":"954_CR50","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","volume":"73","author":"HH van der Zee","year":"2015","unstructured":"van der Zee HH, Jemec GBE. New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes. J Am Acad Dermatol. 2015;73:S23\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2015.07.047.","journal-title":"J Am Acad Dermatol"},{"key":"954_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jdcr.2021.05.029","volume":"14","author":"A Flora","year":"2021","unstructured":"Flora A, Holland R, Smith A, Frew JW. Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab). JAAD Case Rep. 2021;14:33\u20136. https:\/\/doi.org\/10.1016\/j.jdcr.2021.05.029.","journal-title":"JAAD Case Rep"},{"key":"954_CR52","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1099\/mic.0.27788-0","volume":"151","author":"S Valanne","year":"2005","unstructured":"Valanne S, McDowell A, Ramage G, Tunney MM, Einarsson GG, O\u2019Hagan S, et al. CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II. Microbiology (N Y). 2005;151:1369\u201379. https:\/\/doi.org\/10.1099\/mic.0.27788-0.","journal-title":"Microbiology (N Y)"},{"key":"954_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014797","volume":"6","author":"T Nakatsuji","year":"2011","unstructured":"Nakatsuji T, Tang DC, Zhang L, Gallo RL, Huang C-M. Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment. PLoS ONE. 2011;6: e14797. https:\/\/doi.org\/10.1371\/journal.pone.0014797.","journal-title":"PLoS ONE"},{"key":"954_CR54","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.jid.2018.05.032","volume":"138","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hata TR, Tong YL, Kao M-S, Zouboulis CC, Gallo RL, et al. The anti-inflammatory activities of Propionibacterium acnes CAMP factor-targeted acne vaccines. J Investig Dermatol. 2018;138:2355\u201364. https:\/\/doi.org\/10.1016\/j.jid.2018.05.032.","journal-title":"J Investig Dermatol"},{"key":"954_CR55","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/14760584.2019.1593830","volume":"18","author":"S Keshari","year":"2019","unstructured":"Keshari S, Kumar M, Balasubramaniam A, Chang T-W, Tong Y, Huang C-M. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes. Expert Rev Vaccines. 2019;18:433\u20137. https:\/\/doi.org\/10.1080\/14760584.2019.1593830.","journal-title":"Expert Rev Vaccines"},{"key":"954_CR56","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2340\/00015555-3323","volume":"99","author":"A Karoglan","year":"2019","unstructured":"Karoglan A, Paetzold B, Lima J, Br\u00fcggemann H, T\u00fcting T, Schanze D, et al. Safety and efficacy of topically applied selected Cutibacterium acnes strains over five weeks in patients with acne vulgaris: an open-label, pilot study. Acta Dermatol Venereol. 2019;99:1253\u20137. https:\/\/doi.org\/10.2340\/00015555-3323.","journal-title":"Acta Dermatol Venereol"},{"key":"954_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100521","volume":"3","author":"S Lebeer","year":"2022","unstructured":"Lebeer S, Oerlemans EFM, Claes I, Henkens T, Delanghe L, Wuyts S, et al. Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli. Cell Rep Med. 2022;3: 100521. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100521.","journal-title":"Cell Rep Med"},{"key":"954_CR58","unstructured":"Sanofi Pasteur a SC. Study to evaluate safety, efficacy and immunogenicity of acne mRNA vaccine in adults with moderate to severe acne. ClinicalTrialsGov ID NCT06316297. 2025. https:\/\/clinicaltrials.gov\/study\/NCT06316297. Accessed 30 Apr 2025."},{"key":"954_CR59","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41467-023-36694-8","volume":"14","author":"A Rimon","year":"2023","unstructured":"Rimon A, Rakov C, Lerer V, Sheffer-Levi S, Oren SA, Shlomov T, et al. Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions. Nat Commun. 2023;14:1005. https:\/\/doi.org\/10.1038\/s41467-023-36694-8.","journal-title":"Nat Commun"},{"key":"954_CR60","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/ph16121638","volume":"16","author":"B Zalewska-Pi\u0105tek","year":"2023","unstructured":"Zalewska-Pi\u0105tek B. Phage therapy\u2014challenges, opportunities and future prospects. Pharmaceuticals. 2023;16:1638. https:\/\/doi.org\/10.3390\/ph16121638.","journal-title":"Pharmaceuticals"},{"key":"954_CR61","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.it.2019.08.006","volume":"40","author":"A Szegedi","year":"2019","unstructured":"Szegedi A, Dajnoki Z, B\u00edr\u00f3 T, Kem\u00e9ny L, T\u00f6r\u0151csik D. Acne: transient arrest in the homeostatic host-microbiota dialog? Trends Immunol. 2019;40:873\u20136. https:\/\/doi.org\/10.1016\/j.it.2019.08.006.","journal-title":"Trends Immunol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00954-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:03:01Z","timestamp":1757966581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00954-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00954-8","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"12 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by University of Szeged. This work was supported by the National Research, Development and Innovation Office (NKFIH, OTKA K143576 research grant), and received funding from the EU\u2019s Horizon 2020 research and innovation program under grant agreement No. 739593. This project also received funding from the HUN-REN Hungarian Research Network, and the National Research Development and Innovation Fund (project no. TKP2021-EGA-28).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors report no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Participation"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization: LK. Literature review: KL, DD, KS. Writing and critical review of the manuscript: KL, DD, KS. All authors have read and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}